Delivery Order SPE2DB24D9213-SPE2DB25FCGKH
Award Date
2/24/25
Potential Completion Date
3/17/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of NEXPLANON 68 MG IMPLANTS. The contract has a ceiling value of $2,082.93 and an ultimate completion date of February 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. valued at $499,999,999, which enables the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of NEXPLANON 68 MG IMPLANTS. The contract has a ceiling value of $29,587.68 and an ultimate completion date of October 3, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $2,777.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of NEXPLANON 68 MG IMPLANTS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a wide range of pharmaceutical products, including branded and generic...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NEXPLANON 68 MG IMPLANTS. The contract, valued at $8,576.28, has an ultimate completion date of July 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, that allows the DLA to issue firm fixed-price delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The contract has a ceiling value of $3,689.76 and an ultimate completion date of October 17, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to...
The Defense Logistics Agency (DLA) awarded a $5,717.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of NEXPLANON 68 MG IMPLANTS. This delivery order is part of a broader Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $25,728.84 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,565,176,099 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The IDC allows the DLA to issue...
The Defense Logistics Agency (DLA) awarded a $10,005.66 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NEXPLANON 68 MG IMPLANTS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract #SPE2DB22D9124 held by DMS Pharmaceutical Group with DLA, valued up to $4,999,999 through 2025. The IDV enables DLA to issue delivery orders for a broad range of pharmaceutical products to support the medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NEXPLANON 68 MG IMPLANTS. The contract, valued at $5,717.52, has an ultimate completion date of July 15, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) vehicle, valued at up to $499,999,999, under the DLA's SPE2DB program. The IDC allows the DLA to issue firm fixed-price delivery orders...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $82,048.80, is for the delivery of 4562244975 NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. This delivery order contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...